A detailed history of Ascent Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Ascent Group, LLC holds 23,072 shares of ZTS stock, worth $4.08 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
23,072
Previous 33,327 30.77%
Holding current value
$4.08 Million
Previous $5.78 Million 21.98%
% of portfolio
0.35%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $1.77 Million - $2.01 Million
-10,255 Reduced 30.77%
23,072 $4.51 Million
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $354,244 - $435,272
2,434 Added 7.88%
33,327 $5.78 Million
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $1.63 Million - $1.97 Million
9,846 Added 46.78%
30,893 $5.23 Million
Q4 2023

Feb 13, 2024

BUY
$151.44 - $200.09 $180,667 - $238,707
1,193 Added 6.01%
21,047 $4.15 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $46,130 - $53,204
276 Added 1.41%
19,854 $3.45 Million
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $443,872 - $513,622
-2,758 Reduced 12.35%
19,578 $3.37 Million
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $462,044 - $555,863
3,176 Added 16.58%
22,336 $3.72 Million
Q4 2022

Feb 16, 2023

SELL
$131.14 - $157.47 $141,106 - $169,437
-1,076 Reduced 5.32%
19,160 $2.81 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $92,384 - $113,728
623 Added 3.18%
20,236 $3.05 Million
Q2 2022

Aug 05, 2022

BUY
$155.97 - $200.09 $153,786 - $197,288
986 Added 5.29%
19,613 $3.58 Million
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $265,373 - $342,385
1,463 Added 8.52%
18,627 $3.51 Million
Q4 2021

Mar 01, 2022

BUY
$193.69 - $247.03 $3.32 Million - $4.24 Million
17,164 New
17,164 $3.44 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.